Core Points - ePlus inc. has declared its first quarterly cash dividend of $0.25 per common share, to be paid on September 17, 2025, to shareholders of record as of August 26, 2025 [1] - The Board's approval of the dividend reflects the company's commitment to enhancing shareholder value and is supported by its cash generation capabilities [2] Financial Strategy - The company will continue its share repurchase program and consider organic investments and targeted M&A to drive additional shareholder value [2] - The declaration and payment of future dividends will be at the discretion of the Board of Directors [4]

Financial Data and Key Metrics Changes - The company generated total revenue of $3.6 billion in Q2 2025, compared to $3.2 billion in Q2 2024, excluding net recognized gains and losses [12] - Adjusted net earnings were $318 million or $1.16 per diluted share, down from $338 million or $1.24 per share in Q2 2024 [13] - The title segment contributed $260 million to adjusted net earnings, while the F and G segment contributed $89 million [13] Business Line Data and Key Metrics Changes - The title segment generated $2.2 billion in total revenue in Q2 2025, up from $2 billion in Q2 2024, with direct premiums increasing by 12% [14] - Adjusted pretax title earnings were $337 million, a $13 million or 4% increase from the previous year, with a title margin of 15.5% [5][14] - The F and G segment's assets under management grew to $69.2 billion, a 13% increase year-over-year [10] Market Data and Key Metrics Changes - Daily purchase orders opened increased by 5% compared to Q2 2024, while refinance orders saw a significant 28% increase [6][7] - Commercial volumes showed strong performance with direct commercial revenue of $626 million in the first half of 2025, up 23% from $511 million in the same period of 2024 [8] Company Strategy and Development Direction - The company is focused on long-term growth through strategic investments in security, technology, and recruiting [5] - F and G is pursuing a more fee-based, higher-margin, and less capital-intensive business model, supported by the launch of a new reinsurance vehicle [19][20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about a rebound in transaction volumes and the potential for efficiencies across operations [9] - The company anticipates that elevated health claims will normalize in 2026, and they remain confident in maintaining a 15% to 20% pretax title margin [15][45] Other Important Information - The company repurchased 2.9 million shares for $159 million at an average price of $55.2 per share during Q2 2025 [20] - The company returned nearly $300 million of capital to shareholders through dividends and share repurchases in the second quarter [21] Q&A Session Summary Question: Thoughts on holding separate businesses under the same company - Management is pleased with F and G's performance and sees continued value in the current structure, contributing 32% of adjusted earnings [27][28] Question: Details on personnel expenses - Personnel expenses increased due to active recruiting and elevated health claims, with a significant impact from medical claims [29][32] Question: Margin and expense outlook - Management expects health claims to peak this quarter and then moderate, maintaining confidence in the 15% to 20% margin range [44][45] Question: Commercial order momentum - National open orders were up 22% year-over-year, with strong expectations for continued growth in the back half of the year [49][50] Question: Buyback strategy - The company plans to remain active in share buybacks, particularly if share prices show weakness [55][60] Question: Dividend capacity for the second half - Approximately $250 million is available from regulated entities, with an additional $60 million from F and G [67]

Financial Data and Key Metrics Changes - The company reduced its compulsory debts from BRL 20 billion to under BRL 12 billion, showcasing effective liability management [6] - Reported a loss of BRL 1.3 billion due to regulatory remeasurement of transmission contracts, but adjusted net income would have reached BRL 1.4 billion, approximately 40% higher than the previous year [13][14] - EBITDA was impacted by nearly EUR 800 million in equity income, leading to a year-on-year reduction [13] Business Line Data and Key Metrics Changes - Generation margins increased by 21% compared to Q1 and 16% compared to Q2 2024, despite a drop in transmission revenue [10] - Investments grew by 116% compared to Q1 2025, focusing on reinforcements and improvements [11][27] - The company concluded its first post-privatization transmission auction, the Caladinho project, and financial rebalancing for Transnorte Energia [12] Market Data and Key Metrics Changes - The company highlighted a seasonal pattern in energy production, with a decrease in available energy for trading in the dry season [18] - Contribution margins from energy available for trading increased from BRL 1 billion in Q1 to BRL 1.6 billion in Q2 [17] - The company anticipates a more constructive price scenario for 2026 and 2027, despite some volatility [20] Company Strategy and Development Direction - The company aims to improve predictability of results, increase investments, reduce costs, and manage liabilities, transitioning from a turnaround phase to a stable growth phase [8][56] - Future growth opportunities will focus on M&A and auctions, with a strategy to provide more predictable dividends [56] - The company is modernizing its infrastructure and integrating new technologies, aiming to enhance operational efficiency and value generation [58] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's improved risk profile and operational outlook, citing significant reductions in compulsory loans and successful project completions [25][26] - The company is focused on creating resilience in its transmission assets and maintaining a robust investment strategy [39] - Management emphasized the importance of aligning capital allocation with long-term growth and shareholder returns [56] Other Important Information - The company announced a BRL 4 billion dividend payout, reflecting its improved financial position and commitment to shareholder returns [9][27] - The Transnorte Energia project is expected to create 3,500 jobs and reduce carbon emissions significantly [28] Q&A Session Summary Question: Details on trading strategy for Q2 and expected recurring CapEx - Management explained that trading strategies are region-specific, focusing on client value addition and portfolio analysis [32][34] - Recurring CapEx for improvements is expected to be significant, with ongoing investments in assets [38] Question: Internal efforts to accelerate investments and differences in IFRS - Management confirmed that internal processes for investment acceleration are robust and ongoing, with a focus on regulatory alignment [42][44] Question: Expected returns on reinforcements and improvements - Management indicated that returns on regulated investments are expected to converge over time, with a focus on maintaining robust methodologies [50] Question: Liquidity in the energy market and trading decisions - Management noted that liquidity is improving, with a focus on strategic energy allocation based on market conditions [52][64] Question: Company's future focus and dividend strategy - Management outlined a vision for consolidating initiatives and providing predictable dividends, with a focus on growth opportunities [56][58]

Financial Data and Key Metrics Changes - The company achieved record quarterly revenue of $4.4 million, a nearly 50% increase in adjusted EBITDA to $2.4 million compared to the previous quarter [7][9] - Positive free cash flow was reported for the quarter, with cash balances slightly above $5 million, including undrawn revolver capacity [20][21] - The average gold price during the quarter was $3,279 per ounce, contributing to strong cash flows [9] Business Line Data and Key Metrics Changes - Cote mine achieved nameplate throughput with revenue exceeding $1 million in the quarter [11] - Bobrema mine contributed $1.2 million in revenue, maintaining guidance of 33,000 to 40,000 ounces of gold produced for 2025 [12][14] - Revenue from Ignico Eagle's Canadian Malartic mine was reported at $18,000, viewed as a temporary issue due to mine sequencing [13] Market Data and Key Metrics Changes - The company maintains its full-year guidance of 5,700 to 7,000 gold equivalent ounces (GEO) for 2025, despite a guidance cut at Verus mine [14] - The company expects a five-year outlook of 23,000 to 28,000 GEO, primarily from mature and brownfield operations [14] Company Strategy and Development Direction - The company is focused on debt reduction while considering capital returns to shareholders and pursuing strategic growth opportunities [4][5] - There is an expectation of accelerated consolidation in the royalty sector, driven by new strategic capital and recent mergers [5][29] - The company aims to create a mid-tier royalty company with organic growth and sufficient scale to attract global institutional equity investors [5][29] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about a five-year period of pronounced gold equivalent production growth across its portfolio [6] - The company plans to use excess cash to repay outstanding debt, aiming to be effectively debt-free by 2026 [10][36] - Management emphasized the importance of maintaining a disciplined approach to capital allocation and potential acquisitions [16][29] Other Important Information - The company has approximately 20 million outstanding share purchase warrants, exercisable at $2.25 per share [17] - The company is exploring opportunities in safe jurisdictions, primarily in Canada and the US, while also considering investments in Brazil and Australia [35] Q&A Session Summary Question: How was the free cash flow from Q2 2025 handled? - The company generated positive free cash flow and aims to maintain a cash balance above $5 million, with plans to evaluate repayment of the revolver in the coming quarters [20][21] Question: Can you elaborate on Jared Canyon's revenues and expectations? - Revenues from Jared Canyon were related to a settlement, and no further revenues are expected until the mine restarts [22][23] Question: What is the company's stance on the merger landscape? - The company anticipates accelerated consolidation in the royalty space, with a focus on becoming a consolidator in the future [26][29] Question: How far out does the company typically look for acquisitions? - The company focuses on assets with a clear path to cash flow, typically within a five-year window [32] Question: At what point would the company consider reinstating dividends? - The company plans to discuss returning capital to shareholders after achieving a net debt-free position and steady free cash flow generation [36]

Financial Data and Key Metrics Changes - Adjusted net earnings for Q2 2025 were $53 million or $0.26 per share, benefiting from strong metal prices [19] - Consolidated all-in sustaining costs on a byproduct basis in Q2 were $16.52 per ounce, with updated guidance for 2025 now expected to be between $16.50 and $17.50 per ounce [20][21] - Cash flow from operations before working capital and income taxes increased by 22% over the last quarter, totaling $98 million [21] - The cash balance at the end of Q2 was $522 million, resulting in total liquidity of over $920 million [24] Business Line Data and Key Metrics Changes - Mount Milligan produced over 35,000 ounces of gold and 12.4 million pounds of copper in Q2, with updated gold production guidance for 2025 set between 145,000 and 165,000 ounces [13][14] - Aksut's Q2 production was over 28,250 ounces, with reaffirmed 2025 production guidance expected to be higher in the second half of the year [17] - The restart of Thompson Creek is advancing, with approximately 20% of the total capital investment complete [18] Market Data and Key Metrics Changes - The average realized price for gold was $2,793 per ounce and for copper was $3.62 per pound in Q2 [20] - The molybdenum business unit sold approximately 3.1 million pounds at an average realized price of $21.43 per pound [20] Company Strategy and Development Direction - The company is advancing its internal growth strategy with projects like Goldfield, Mount Milligan, and Chemess, all expected to be self-funded from existing liquidity [25][26] - The Goldfield project is expected to enhance near-term gold production and is projected to have an after-tax NPV of $245 million and an IRR of 30% [9][10] - The company is focused on sustainability initiatives, achieving compliance with the International Cyanide Management Code and increasing local procurement spending by 26% year over year [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational focus and future performance of Mount Milligan under new leadership [6] - The company anticipates strong free cash flow generation in the second half of 2025, particularly from Oksut [22] - Management highlighted the importance of maintaining financial strength and flexibility while pursuing growth opportunities [26] Other Important Information - The company has implemented a targeted hedging strategy on 50% of gold production for 2029 and 2030, with a price floor of $3,200 per ounce [9] - The company has surpassed its 2026 gender diversity goal, with women representing 38% of the Board and 33% of executive officers [12] Q&A Session Summary Question: Can you provide an update on Mount Milligan's mineralization challenges? - Management confirmed increased density of drilling in the area, leading to improved confidence in future predictions [28] Question: What has changed regarding the Goldfield project since last year? - The company has conducted technical work that improved recovery rates and the favorable gold price has enhanced the project's attractiveness [30] Question: How does the company plan to finance multiple projects? - The company has sufficient liquidity to fund all projects while continuing share buybacks, emphasizing a strong balance sheet [33][60] Question: What is the timeline for Goldfield's first production? - Most permits are in place, with minor amendments needed, and the critical path involves engineering and procurement activities [44][46] Question: How does the updated royalty structure affect Oksut? - The royalty structure has been expanded to account for higher gold prices, with a sliding scale for increases [54] Question: What is the strategic rationale for pursuing Goldfield? - The project offers high IRR and NPV, and the company believes it can balance capital allocation between growth projects and shareholder returns [56][60]

Financial Data and Key Metrics Changes - Q1 sales were approximately $250 million, which was below the forecast of $258 million to $260 million, representing a year-over-year decline largely due to supply chain issues in eye care [6][12] - Gross margin expanded by 150 basis points to 56.2%, attributed to ongoing cost savings efforts [8][12] - Diluted EPS was $0.95, up approximately 6% compared to the adjusted prior year, despite the sales miss [9][16] - Free cash flow reached a quarterly record of $78 million, enabling capital deployment to enhance shareholder value [9][17] Business Line Data and Key Metrics Changes - North America segment revenues decreased by 8.4%, while International segment revenues increased by 7.1% year-over-year [13] - The International segment experienced organic sales growth of 7%, driven by broad-based sales growth [14] Market Data and Key Metrics Changes - The company anticipates a full-year revenue of $1.1 billion to $1.115 billion, with organic revenue expected to decline approximately 1.5% to 3% [22] - For Q2, revenues are expected to be approximately $256 million to $259 million, down year-over-year due to supply chain timing and lower retail order patterns [22] Company Strategy and Development Direction - The company announced the acquisition of Pillar Five to secure and expand long-term supply for eye care products, which is expected to improve supply stability in the second half of the year [11][19] - The company maintains confidence in its diverse consumer healthcare portfolio and long-term growth opportunities despite the disappointing start to the year [21] Management Comments on Operating Environment and Future Outlook - Management highlighted heightened business environment uncertainty due to supply chain constraints, high inflation, and geopolitical events [5] - The company expects significant improvement in Clear Eye shipments in the second half of the year, with a focus on recovering lost sales in FY 2027 and beyond [22][29] Other Important Information - The anticipated cost of tariffs for the full year is approximately $5 million, which the company expects to offset through strategic actions [15] - The acquisition of Pillar Five is expected to be funded from cash on hand and will have a minimal impact on the P&L, being approximately neutral to EPS on a normalized basis [19][63] Q&A Session Summary Question: Change in retail order patterns and inventory destocking - Management noted increased order volatility from retailers in July, which is expected to significantly impact Q2 but anticipates a return to normalized order trends in the second half [25][26] Question: Confidence in Clear Eyes supply normalizing - Management expressed confidence in supply normalizing in the back half of the year, with expectations of recovering lost sales in FY 2027 and beyond [29][30] Question: Impact of bringing eye care manufacturing in-house on margins - Management does not expect any meaningful movement in gross margin as a result of the acquisition of Pillar Five, indicating it will be largely neutral to the P&L [37][38] Question: Inventory levels and destocking expectations - Management does not see any meaningful ramp-up of inventory among their largest customers, indicating that inventory levels are not inflated [45][46] Question: Performance of the women's health business - Management remains optimistic about the continued recovery of the Summer's Eve brand, expecting positive performance for the remainder of the year [48] Question: Sustaining international growth - Management is confident in sustaining international growth, expecting a slight softening compared to the first quarter but still in line with long-term growth algorithms [70]

Financial Data and Key Metrics Changes - The company achieved a record performance in Q2 2025 with a 35% year-over-year revenue growth, reaching $234.5 million, and a 70% increase in consolidated adjusted EBITDA to $39.6 million, representing a 16.9% margin [7][20] - Year-to-date revenues increased by 25.5% to $412.4 million, with year-to-date consolidated adjusted EBITDA rising 46% to $58.6 million, or 14.2% of revenue [20][21] - The company reported positive GAAP net income of $18.4 million, or $0.42 per diluted share, compared to a net loss of $10.2 million in the prior year [21][22] Business Line Data and Key Metrics Changes - In the Assessment, Permitting and Response segment, Q2 revenue nearly doubled to $103.9 million, with adjusted EBITDA of $27.6 million, or 26.5% of revenue [23] - The Measurement and Analysis segment saw a revenue increase of nearly 15% to $62.8 million, with adjusted EBITDA rising to $18.3 million, or 29.1% of revenue [24][25] - The Remediation and Reuse segment's revenue increased to $67.8 million, with adjusted EBITDA growing to $10 million and a margin of 14.8% [26] Market Data and Key Metrics Changes - 80% of 2024 revenue was generated from U.S. clients, primarily in the private sector, indicating strong demand across various industries [13] - The company noted increased regulatory influence from local and state governments in the U.S., which is expected to drive continued demand for its services [14][15] Company Strategy and Development Direction - The company is focused on driving strong organic growth, generating solid cash flow, and simplifying its balance sheet, with a long-term organic revenue growth expectation of 7% to 9% annually [11][12] - The strategic priorities include capital allocation to high-return opportunities, emphasizing scalable profitability, and increasing operating and free cash flow generation [17][19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about current and future business prospects, citing ongoing client demand for environmental science-based solutions [17] - The company anticipates minimal impact from regulatory uncertainties related to greenhouse gas regulations, as most clients operate in states with active regulations [15][16] Other Important Information - The company completed the redemption of remaining preferred shares, bringing leverage below three times pro forma [11] - The company raised its guidance for 2025, expecting revenue to surpass 2024 by 17% and adjusted EBITDA to grow 19% [12] Q&A Session Summary Question: Margins across business lines - Management indicated that margins in the Measurement and Analysis segment are expected to remain in the 18% to 22% range long-term, despite current strong performance due to operating leverage and project mix shifts [30][31] Question: Emergency response business outlook - Management noted that emergency response work is seen as an upside opportunity, with core business growth continuing independently [45][46] Question: Customer concerns - Management acknowledged that customers are dealing with macroeconomic factors but noted that planning cycles remain stable, sustaining demand for services [59][60] Question: Acquisition strategy - Management confirmed that while acquisitions are currently paused, there is a robust opportunity for future consolidation in the market [62][63] Question: PFAS activity and treatment - Management expressed optimism about the PFAS treatment business, noting regulatory developments and a growing patent portfolio that expands service offerings [39][94] Question: Organic growth drivers - Management attributed organic growth to deepening relationships with existing clients and regulatory shifts, rather than acquiring new clients [100][101]

Financial Data and Key Metrics Changes - Q1 sales were approximately $250 million, which was below the forecast of $258 million to $260 million, representing a year-over-year decline largely due to supply chain issues and lower sales in eye care [5][10] - Gross margin expanded by 150 basis points to 56.2%, attributed to cost savings efforts [6][12] - Diluted EPS was $0.95, up approximately 6% from the adjusted prior year, despite the sales miss [7][14] - Free cash flow reached a record $78 million, enabling capital deployment for shareholder value enhancement [7][15] Business Line Data and Key Metrics Changes - North America segment revenues decreased by 8.4%, while International segment revenues increased by 7.1% year-over-year [11][12] - The eye care segment faced significant supply constraints, impacting sales, while other segments like Dramamine and Fleet showed healthy consumption trends [6][12] Market Data and Key Metrics Changes - The International segment experienced organic sales growth of 7%, driven by broad-based sales growth [12] - E-commerce channel saw double-digit year-over-year consumption growth, indicating a long-term trend towards higher online purchasing [12] Company Strategy and Development Direction - The company announced the acquisition of Pillar Five to secure and expand long-term supply for eye care products, which is expected to improve supply stability in the second half of the year [9][17] - The company anticipates revenues for fiscal 2026 to be between $1.1 billion and $1.115 billion, with organic revenue expected to decline approximately 1.5% to 3% [20] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment in the start of the year but remains confident in the long-term growth opportunities of their consumer healthcare portfolio [19] - The company expects significant improvement in Clear Eye shipments in the second half of the year, despite current supply chain challenges [20][29] Other Important Information - The company maintained a leverage ratio of approximately 2.4 times and repurchased over 400,000 shares in Q1 [7][15] - The anticipated cost of tariffs for the full year is approximately $5 million, which the company expects to offset through strategic actions [13] Q&A Session Summary Question: Change in retail order patterns and inventory destocking - Management noted increased order volatility from retailers in July, disconnected from consistent consumption levels, impacting Q2 significantly [23][24] Question: Confidence in supply normalizing for Clear Eyes - Management expressed confidence in supply normalizing in the back half of the year, with new suppliers and a high-speed line expected to contribute [26][29] Question: Impact of bringing eye care manufacturing in-house on margins - Management indicated no meaningful movement in gross margin as a result of bringing manufacturing in-house, expecting it to be largely neutral to the P&L [36][39] Question: Outlook for cough and cold season - Management maintained the initial guidance for a modest decline in the cough and cold category, too early to tell at this point [42] Question: Inventory levels within segments - Management reported no meaningful ramp-up of inventory, indicating that current order patterns are disconnected from consumption [44] Question: Performance of Summer's Eve brand - Management expressed confidence in the continued positive momentum of the Summer's Eve brand for the remainder of the year [46] Question: International segment growth sustainability - Management expects to sustain international growth, projecting a long-term algorithm of over 5% for the segment [68]

Financial Data and Key Metrics Changes - CRH reported total revenues of $10.2 billion for Q2 2025, a 6% increase compared to the prior year, driven by favorable underlying demand and strong contributions from acquisitions [9][10] - Adjusted EBITDA for the quarter was $2.5 billion, reflecting a 9% increase year-over-year, with a margin expansion of 70 basis points [10][19] - The company raised its full-year adjusted EBITDA guidance to between $7.5 billion and $7.7 billion, indicating a 10% growth at the midpoint [9][33] Business Line Data and Key Metrics Changes - Americas Materials Solutions saw a 24% increase in total revenues and adjusted EBITDA compared to the prior year, despite adverse weather conditions [11] - Essential Materials reported a 4% increase in revenues, supported by increased volumes and positive pricing momentum in Aggregates and Cement [11] - International Solutions experienced a 13% increase in revenue and a 23% increase in adjusted EBITDA, with significant margin expansion [15] Market Data and Key Metrics Changes - Infrastructure, the largest end market for CRH, continues to benefit from state and federal funding, with less than 40% of IIJA highway funding deployed to date [13][30] - The residential sector in the U.S. is expected to remain subdued, while repair and remodel activities are resilient [31][32] - Positive pricing momentum is anticipated across markets, supported by disciplined commercial management [32] Company Strategy and Development Direction - CRH is focused on reinvesting in high-growth markets and has allocated approximately $1.7 billion across 19 acquisitions and growth CapEx investments [7][20] - The acquisition of EcoMaterial Technologies is expected to enhance CRH's cementitious growth strategy, significantly increasing its production capacity [23][24] - The company emphasizes a connected portfolio strategy to maximize profitability and operational efficiencies across its business segments [25][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying demand across key markets and noted that backlogs are ahead of the prior year [8][40] - The company anticipates continued strong performance in the second half of the year, driven by favorable weather conditions and robust backlogs [40] - Management highlighted the importance of federal and state funding in driving infrastructure demand, with expectations for a supportive legislative environment for future funding [54][56] Other Important Information - CRH has declared a quarterly dividend of $0.37 per share, representing a 6% increase year-over-year, and has repurchased approximately $800 million in shares so far this year [21][22] - The company has a strong pipeline of growth opportunities and plans to maintain a disciplined capital allocation strategy [34][78] Q&A Session Summary Question: Drivers of the full-year guidance increase - Management noted strong Q2 performance with EBITDA up 9% and margins up 70 basis points, despite challenging weather conditions [37] - Infrastructure remains robust, with significant backlogs and positive momentum in July [40] Question: Expectations for U.S. Cement and aggregates - Underlying aggregate volumes were up 5% and pricing up 4% in Q2, with expectations for mid to high single-digit pricing growth for the full year [45][46] Question: Update on federal infrastructure funding - Management indicated a supportive bipartisan environment for the next highway bill, with a focus on surface transportation [54][56] Question: Performance of Adbri and margin expansion drivers - Adbri has performed well since acquisition, and margin expansion is attributed to tight cost control and operational efficiencies [100]

Financial Performance & Capital Allocation - The company returned over $190 million to shareholders in the first half of 2025, including $46 million in 2Q 2025[6] - The company is targeting long-term debt of $1 billion[8, 24] - The board authorized a share repurchase program of $550 million[11] - The company is allocating a minimum of 50% of adjusted free cash flow to share buybacks and potential dividend increases[6, 8, 81] Production & Operations - Second quarter 2025 production reached 190 MBOEPD (thousands of barrels of oil equivalent per day)[5, 19, 20] - Eagle Ford Shale production was 39 MBOEPD, representing 21% of total production[19, 36] - Offshore production was 72 MBOEPD, accounting for 38% of total production[19, 46] - Onshore Canada production was 79 MBOEPD, making up 41% of total production[19, 41] Exploration & Development - The company is progressing with the Lac Da Vang (Golden Camel) project in Vietnam, targeting first oil in 4Q 2026, with an estimated gross recoverable resource of 100 MMBOE (millions of barrels of oil equivalent)[53, 80, 83] - The company plans to spud the Civette well in Côte d'Ivoire in 4Q 2025, with a mean to upward gross resource potential of 440 MMBOE – 1,000 MMBOE[71]